259 related articles for article (PubMed ID: 32946161)
21. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis of New Pyridine and Pyrimidine Sugar Compounds as Antagonists Targeting the ERα via Structure-Based Virtual Screening.
Nassar IF; El-Sayed WA; Ragab TIM; Shalaby ASG; Mehany ABM
Mini Rev Med Chem; 2019; 19(5):395-409. PubMed ID: 30124151
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of certain pyrimidine derivatives as antimicrobial agents and anti-inflammatory agents.
Mohamed MS; Awad SM; Sayed AI
Molecules; 2010 Mar; 15(3):1882-90. PubMed ID: 20336018
[TBL] [Abstract][Full Text] [Related]
24. One pot multi-component synthesis of functionalized spiropyridine and pyrido[2,3-d]pyrimidine scaffolds and their potent in-vitro anti-inflammatory and anti-oxidant investigations.
Lavanya M; Asharani IV; Thirumalai D
Chem Biol Drug Des; 2019 Apr; 93(4):464-472. PubMed ID: 30393996
[TBL] [Abstract][Full Text] [Related]
25. Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery.
Keshari AK; Singh AK; Saha S
Mini Rev Med Chem; 2017; 17(15):1488-1499. PubMed ID: 28215139
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activity of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors.
Taltavull J; Serrat J; Gràcia J; Gavaldà A; Andrés M; Córdoba M; Miralpeix M; Vilella D; Beleta J; Ryder H; Pagès L
J Med Chem; 2010 Oct; 53(19):6912-22. PubMed ID: 20825218
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies.
Santhosh Kumar G; Poornachandra Y; Kumar Gunda S; Ratnakar Reddy K; Mohmed J; Shaik K; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2018 Jul; 28(13):2328-2337. PubMed ID: 29798826
[TBL] [Abstract][Full Text] [Related]
28. Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.
Carta A; Sanna P; Gherardini L; Usai D; Zanetti S
Farmaco; 2001 Dec; 56(12):933-8. PubMed ID: 11829113
[TBL] [Abstract][Full Text] [Related]
29. Expanding the scope of fused pyrimidines as kinase inhibitor scaffolds: synthesis and modification of pyrido[3,4-d]pyrimidines.
Innocenti P; Woodward H; O'Fee L; Hoelder S
Org Biomol Chem; 2015 Jan; 13(3):893-904. PubMed ID: 25407826
[TBL] [Abstract][Full Text] [Related]
30. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the chemistry and biology of pyridopyrimidines.
Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
[TBL] [Abstract][Full Text] [Related]
32. Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors.
Wissing J; Godl K; Brehmer D; Blencke S; Weber M; Habenberger P; Stein-Gerlach M; Missio A; Cotten M; Müller S; Daub H
Mol Cell Proteomics; 2004 Dec; 3(12):1181-93. PubMed ID: 15475568
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of certain alpha,beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents.
El-Subbagh HI; Abu-Zaid SM; Mahran MA; Badria FA; Al-Obaid AM
J Med Chem; 2000 Jul; 43(15):2915-21. PubMed ID: 10956199
[TBL] [Abstract][Full Text] [Related]
34. Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.
Chauhan M; Kumar R
Bioorg Med Chem; 2013 Sep; 21(18):5657-68. PubMed ID: 23932070
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family.
Smaill JB; Gonzales AJ; Spicer JA; Lee H; Reed JE; Sexton K; Althaus IW; Zhu T; Black SL; Blaser A; Denny WA; Ellis PA; Fakhoury S; Harvey PJ; Hook K; McCarthy FO; Palmer BD; Rivault F; Schlosser K; Ellis T; Thompson AM; Trachet E; Winters RT; Tecle H; Bridges A
J Med Chem; 2016 Sep; 59(17):8103-24. PubMed ID: 27491023
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
[TBL] [Abstract][Full Text] [Related]
37. A novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: synthesis, anti-inflammatory and antimicrobial evaluation.
Keche AP; Hatnapure GD; Tale RH; Rodge AH; Birajdar SS; Kamble VM
Bioorg Med Chem Lett; 2012 May; 22(10):3445-8. PubMed ID: 22520258
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, in vitro antimicrobial and cytotoxic activities of novel pyrimidine-benzimidazol combinations.
Chen PJ; Yang A; Gu YF; Zhang XS; Shao KP; Xue DQ; He P; Jiang TF; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Jun; 24(12):2741-3. PubMed ID: 24798098
[TBL] [Abstract][Full Text] [Related]
39. A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles.
Seth S
Antiinflamm Antiallergy Agents Med Chem; 2015; 14(2):98-112. PubMed ID: 26017385
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
